Sponsored
TrialCard has a new name and brand: Mercalis. The Triangle-based company that works with life science companies on commercialization efforts, announced the change on Wednesday.
Sponsored
Federal regulators declined to approve a nasal spray from a San Diego company to treat severe allergic reactions late Tuesday, calling for more research on what would have been the first alternative to injections using devices such as an EpiPen. A Raleigh firm also has a nasal spray alternative under development.
Sponsored
Nancie M. Archin, assistant professor of medicine in the division of infectious diseases at the UNC School of Medicine, was recently awarded the International Society for Antiviral Research Diversity in Science and Excellence award.
Sponsored
Novo Nordisk’s shares fell on Monday after financial news agency MarketWire reported that U.S. drug regulators had recently issued a report detailing quality control lapses at the group’s Clayton plant, citing sources.
Sponsored
NC State researchers’ findings could lead to better ways of producing hybrid seeds to maximize crop productivity, or to introduce seedlessness in fruit species lacking the often-desired trait, such as raspberries, blackberries or muscadine grapes.
Sponsored
The opening of TARGAN’s headquarters not only marked a significant milestone for TARGAN but also brought attention to the region’s ongoing growth in the life sciences industry.
Sponsored
Jacob Jacobsen, a co-founder of Evecxia Therapeutics along with the late Marc Caron and a former Duke University professor, is now the firm’s chief executive officer.
Sponsored
Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park focused on restoring bowel and bladder control for elderly and neurologically impaired people, has added a new compound to its product pipeline.
Sponsored
Seventeen employees at Sage Therapeutics’ operation in Brier Creek are being laid off. Here are the details.
Sponsored
Durham-based Restor3d, a medical device company, has raised $17 million from investors, according to an SEC filing. Here are the details.
